Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome

Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome

Metabolic syndrome (MetS) represents a combination of cardiometabolic risk factors, including visceral obesity, glucose intolerance or type 2 diabetes, elevated triglycerides, reduced HDL cholesterol, and hypertension. MetS is rapidly increasing in prevalence worldwide as a consequence of the “epide...

Full description

Bibliographic Details
Main Authors:	Tiziana Di Chiara, Christiano Argano, Salvatore Corrao, Rosario Scaglione, Giuseppe Licata
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Journal of Nutrition and Metabolism
Online Access:	http://dx.doi.org/10.1155/2012/175245

Similar Items

Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: A 24-week randomized controlled double-dummy trial
by: Salvatore Corrao, et al.
Published: (2006-05-01)

The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects
by: Rosario Scaglione, et al.
Published: (2010-01-01)

Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study
by: Pizzo Federica, et al.
Published: (2008-05-01)

High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome
by: Hirata Ayumu, et al.
Published: (2012-01-01)

Hypoadiponectinemia in obese subjects with type II diabetes: A close association with central obesity indices
by: Ghorban Mohammadzadeh, et al.
Published: (2011-01-01)

Hypoadiponectinemia: A useful marker of dyslipidemia in women with polycystic ovary syndrome
by: Chih-Yuan Chang, et al.
Published: (2012-12-01)

Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study
by: Chang-Yun Yoon, et al.
Published: (2016-11-01)

Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
by: Jessie A. Elliott, et al.
Published: (2021-03-01)

Immune Response Failure in Paucisymptomatic Long-Standing SARS-CoV-2 Spreaders
by: Salvatore Corrao, et al.
Published: (2021-03-01)

Association of Hypoadiponectinemia with Hypoglutathionemia in NAFLD Subjects with and without Type 2 Diabetes
by: Narasimhan Sandhya, et al.
Published: (2010-01-01)

Prevalence of hypovitaminosis D, and its association with hypoadiponectinemia and hyperfollistatinemia, in Saudi women with naïve polycystic ovary syndrome
by: Osama Adnan Kensara
Published: (2018-06-01)

Type 2 Diabetes Mellitus and COVID-19: A Narrative Review
by: Salvatore Corrao, et al.
Published: (2021-03-01)

Metabolic syndrome and visceral fat thickness in obese adolescents
by: Lanny C. Gultom, et al.
Published: (2007-07-01)

Algorithm for radiological examination of visceral obesity in patients with metabolic syndrome
by: N. M. Suslyayeva, et al.
Published: (2012-10-01)

ALTERNATIVE METHOD OF VISCERAL OBESITY ASSESSMENT IN THE DIAGNOSTICS OF METABOLIC SYNDROME
by: N. G. Veselovskaya, et al.
Published: (2014-03-01)

HYPOADIPONECTINEMIA AND DYSLIPIDEMIA IN RELATION TO GLYCEMIC STATUS IN TYPE 2 DIABETES AND CORONARY HEART DISEASE
by: Sadaf Durrani, et al.
Published: (2014-12-01)

Hypoadiponectinemia in extremely low gestational age newborns with severe hyperglycemia--a matched-paired analysis.
by: Andre Oberthuer, et al.
Published: (2012-01-01)

Inflammation as a Link between Obesity and Metabolic Syndrome
by: Faloia Emanuela, et al.
Published: (2012-01-01)

Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
by: Ana P. Santos, et al.
Published: (2018-08-01)

Immunological Characteristics of Non-Intensive Care Hospitalized COVID-19 Patients: A Preliminary Report
by: Salvatore Corrao, et al.
Published: (2021-02-01)

NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis.
by: Anna Licata, et al.
Published: (2013-01-01)

Role of Vitamin A Metabolism in Visceral Obesity
by: Yasmeen, Rumana
Published: (2012)

Leptin in sarcopenic visceral obesity: possible link between adipocytes and myocytes.
by: Katsuhiko Kohara, et al.
Published: (2011-01-01)

Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes
by: Sadia Mehmood, et al.
Published: (2018-10-01)

Altered clock gene expression in obese visceral adipose tissue is associated with metabolic syndrome.
by: Elaine Vieira, et al.
Published: (2014-01-01)

Higher Hepcidin Levels in Adolescents with Obesity Are Associated with Metabolic Syndrome Dyslipidemia and Visceral Fat
by: Reyna Rodríguez-Mortera, et al.
Published: (2021-05-01)

Docosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?
by: Carlotta Lassandro, et al.
Published: (2015-08-01)

OPPORTUNITIES FOR THE USE OF VISCERAL OBESITY INDEX IN METABOLIC SYNDROME DIAGNOSTICS AND PROGNOSIS OF ITS COMPLICATION RISK
by: R. A. Libis, et al.
Published: (2014-09-01)

Repeated sense of hunger leads to the development of visceral obesity and metabolic syndrome in a mouse model.
by: Jong-Min Han, et al.
Published: (2014-01-01)

Combined impact of cardiorespiratory fitness and visceral adiposity on metabolic syndrome in overweight and obese adults in Korea.
by: Sue Kim, et al.
Published: (2014-01-01)

Chronic Inflammation in Obesity and the Metabolic Syndrome
by: Rosário Monteiro, et al.
Published: (2010-01-01)

Does Evidence Exist to Blunt Inflammatory Response by Nutraceutical Supplementation during COVID-19 Pandemic? An Overview of Systematic Reviews of Vitamin D, Vitamin C, Melatonin, and Zinc
by: Salvatore Corrao, et al.
Published: (2021-04-01)

Visceral Obesity-Related Indices in the Identification of Individuals with Metabolic Syndrome Among Different Ethnicities in Xinjiang, China
by: Zhang X, et al.
Published: (2021-04-01)

Analysis of lifestyle and metabolic predictors of visceral obesity with Bayesian Networks
by: de Morais Sérgio, et al.
Published: (2010-09-01)

Importance of Visceral Obesity and Testosterone Deficiency in the formation of metabolic disorders in men
by: Z. R. Gusova, et al.
Published: (2019-09-01)

The impact of metabolic syndrome and visceral adiposity on colon cancer
by: Ana Luísa Pinto da Silva
Published: (2021)

<it>LINE-1</it> methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes
by: Turcot Valérie, et al.
Published: (2012-07-01)

Visceral Adiposity Index (VAI) in Children and Adolescents with Obesity: No Association with Daily Energy Intake but Promising Tool to Identify Metabolic Syndrome (MetS)
by: Sara Vizzuso, et al.
Published: (2021-01-01)

Obesity, metabolism and the microenvironment: Links to cancer
by: Sneha Sundaram, et al.
Published: (2013-01-01)

The Link between the Metabolic Syndrome and Cancer
by: Braun Sandra, Bitton-Worms Keren, LeRoith Derek
Published: (2011-01-01)